CompletedNCT04741412
Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences
Studying Ectodermal dysplasia syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Erlangen
- Principal Investigator
- Holm Schneider, MDUniversity Hospital Erlangen
- Enrollment
- 231 enrolled
- Eligibility
- All sexes
- Timeline
- 2020 – 2021
Study locations (1)
- University Hospital Erlangen, Erlangen, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04741412 on ClinicalTrials.govOther trials for Ectodermal dysplasia syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07468019Organization's Unique Protocol IDCairo University
- ACTIVE NOT RECRUITINGNCT07096206Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International StudyPierre Fabre Medicament
- RECRUITINGPHASE2NCT04980638Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal DysplasiaEspeRare Foundation